The governance structure for data access in the DIRECT consortium: an innovative medicines initiative (IMI) project.

Loading...
Thumbnail Image
Authors
Teare, H. J. A.
de Masi, F.
Banasik, K.
Barnett, A.
Herrgard, S.
Jablonka, B.
Postma, J. W. M.
McDonald, Timothy J.
Forgie, I.
Chmura, P. J.
Journal
Life sciences, society and policy
Type
Journal Article
Publisher
Springer
Rights
Archived with thanks to Life sciences, society and policy. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Biomedical research projects involving multiple partners from public and private sectors require coherent internal governance mechanisms to engender good working relationships. The DIRECT project is an example of such a venture, funded by the Innovative Medicines Initiative Joint Undertaking (IMI JU). This paper describes the data access policy that was developed within DIRECT to support data access and sharing, via the establishment of a 3-tiered Data Access Committee. The process was intended to allow quick access to data, whilst enabling strong oversight of how data were being accessed and by whom, and any subsequent analyses, to contribute to the overall objectives of the consortium.
Citation
The governance structure for data access in the DIRECT consortium: an innovative medicines initiative (IMI) project. 2018, 14 (1):20 Life Sci Soc Policy
Note
This article is freely available via Open Access.